优化他汀相关肌肉症状患者的胆固醇治疗
本文综述了他汀不耐受的定义,提出更明确界定他汀不耐受的算法,并描述在报告他汀相关肌肉症状的个体中优化心血管风险降低的策略。报告他汀不耐受的患者心血管事件风险高,需通过降低LDL-C优化风险降低。
要点
- 他汀通过降低LDL-C高效预防心血管事件,但肌肉症状常妨碍指南推荐剂量使用。
- 报告他汀不耐受者心血管事件风险高,需优化LDL-C降低策略。
- 本文提出界定他汀不耐受的算法及管理他汀相关肌肉症状的方法。
核心结论
- 报告他汀不耐受的患者心血管事件风险高,需通过降低LDL-C优化心血管风险降低策略。
研究设计与样本
- 综述:回顾他汀不耐受定义,提出界定算法,描述优化风险降低的方法。
主要发现
- 他汀通过降低LDL-C高效预防心血管事件,但许多患者报告肌肉相关症状妨碍指南推荐剂量使用。
- 报告他汀不耐受的患者心血管事件风险高。
临床怎么用
- 对报告他汀相关肌肉症状者,应应用优化LDL-C降低的策略以降低心血管风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Statins are highly effective for preventing cardiovascular events by reducing low-density lipoprotein cholesterol (LDL-C). However, many patients taking statins report muscle-related symptoms that prevent the use of guideline recommended doses. Patients with reported intolerance to statins have a high risk of cardiovascular events. Clinical strategies that optimize cardiovascular risk reduction through LDL-C lowering need to be applied in patients experiencing intolerable side effects that they attribute to statins. In this paper, the authors review definitions of statin intolerance, propose algorithms to better define statin intolerance, and describe approaches to optimize cardiovascular risk reduction among individuals reporting statin-associated muscle symptoms.
引用
- Rosenson RS, Baker S, Banach M, et al. Optimizing Cholesterol Treatment in Patients With Muscle Complaints. J Am Coll Cardiol. 2017. PMID: 28859793. doi:10.1016/j.jacc.2017.07.752
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。